- Home
- NBIX vs MDB Comparison
NBIX vs MDB Comparison
Compare NBIX & MDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBIX
- MDB
- Stock Information
- Founded
- NBIX 1992
- MDB 2007
- Country
- NBIX United States
- MDB United States
- Employees
- NBIX N/A
- MDB N/A
- Industry
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- MDB Computer Software: Prepackaged Software
- Sector
- NBIX Health Care
- MDB Technology
- Exchange
- NBIX Nasdaq
- MDB Nasdaq
- Market Cap
- NBIX 13.2B
- MDB 15.8B
- IPO Year
- NBIX 1996
- MDB 2017
- Fundamental
- Price
- NBIX $139.60
- MDB $309.13
- Analyst Decision
- NBIX Strong Buy
- MDB Strong Buy
- Analyst Count
- NBIX 18
- MDB 34
- Target Price
- NBIX $160.94
- MDB $317.59
- AVG Volume (30 Days)
- NBIX 782.5K
- MDB 4.0M
- Earning Date
- NBIX 10-29-2025
- MDB 08-26-2025
- Dividend Yield
- NBIX N/A
- MDB N/A
- EPS Growth
- NBIX 2.97
- MDB N/A
- EPS
- NBIX 3.39
- MDB N/A
- Revenue
- NBIX $2,509,900,000.00
- MDB $2,218,189,000.00
- Revenue This Year
- NBIX $20.66
- MDB $15.23
- Revenue Next Year
- NBIX $14.64
- MDB $15.87
- P/E Ratio
- NBIX $40.91
- MDB N/A
- Revenue Growth
- NBIX 18.42
- MDB 21.91
- 52 Week Low
- NBIX $84.23
- MDB $140.78
- 52 Week High
- NBIX $154.61
- MDB $370.00
- Technical
- Relative Strength Index (RSI)
- NBIX 68.09
- MDB 78.34
- Support Level
- NBIX $133.62
- MDB $212.31
- Resistance Level
- NBIX $137.03
- MDB $321.57
- Average True Range (ATR)
- NBIX 2.36
- MDB 10.31
- MACD
- NBIX 0.83
- MDB 11.37
- Stochastic Oscillator
- NBIX 97.44
- MDB 97.12
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About MDB MongoDB Inc.
Founded in 2007, MongoDB is a vendor of a document-oriented database that accelerates development processes of new applications. Enterprise customers can choose between the fully managed offering, MongoDB Atlas, or the self-managed version, MongoDB Enterprise Advanced. MongoDB is a popular tool among developers, and its free Community Server has recorded over 500 million downloads since 2009.